Paper12912922
Identification of the RNA polymerase II subunit hsRPB7 as a novel target of the von Hippel-Lindau protein.
Na X and 7 others. EMBO J, 2003. Cited by 81 papers, by iCite.
Cite this record
ConductScience Library. Identification of the RNA polymerase II subunit hsRPB7 as a novel target of the von Hippel-Lindau protein. Papers, record 12912922. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12912922
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Identification of the RNA polymerase II subunit hsRPB7 as a novel target of the von Hippel-Lindau protein.
- PubMed
Topics26
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Protein Subunits | Major topic |
| Proteins | Major topic |
| RNA Polymerase II | Major topic |
| von Hippel-Lindau Disease | Major topic |
| Cell Nucleus | |
| Cysteine Endopeptidases | |
| Endothelial Growth Factors | |
| Gene Expression Regulation, Neoplastic | |
| HeLa Cells | |
| Humans | |
| Intercellular Signaling Peptides and Proteins | |
| Kidney Neoplasms | |
| Lymphokines | |
| Multienzyme Complexes | |
| Mutation | |
| Promoter Regions, Genetic | |
| Proteasome Endopeptidase Complex | |
| Protein Isoforms | |
| Protein Structure, Tertiary | |
| RNA, Messenger | |
| Transcriptional Activation | |
| Transfection | |
| Tumor Cells, Cultured | |
| Ubiquitins | |
| Vascular Endothelial Growth Factor A | |
| Vascular Endothelial Growth Factors |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P30 CA006927 | NCI NIH HHS | United States | P01CA006927 | PubMed and NIH | NIH RePORTER |
| CA-06927 | NCI NIH HHS | United States | P01CA006927 | PubMed and NIH | NIH RePORTER |
| P30CA006927 | NIH | NIH RePORTER |
References39
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10353251 | The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. | Nature | 1999 | https://conductscience.org/library/papers/10353251 | PubMed |
| 2 | 9829926 | Rpb4, a subunit of RNA polymerase II, enables the enzyme to transcribe at temperature extremes in vitro. | J Bacteriol | 1998 | https://conductscience.org/library/papers/9829926 | PubMed |
| 3 | 10082533 | Rpb7 can interact with RNA polymerase II and support transcription during some stresses independently of Rpb4. | Mol Cell Biol | 1999 | https://conductscience.org/library/papers/10082533 | PubMed |
| 4 | 10878807 | Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein. | Nat Cell Biol | 2000 | https://conductscience.org/library/papers/10878807 | PubMed |
| 5 | 10535940 | Identification of the von Hippel-lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex. | Proc Natl Acad Sci U S A | 1999 | https://conductscience.org/library/papers/10535940 | PubMed |
| 6 | 9528765 | Analysis of the interaction of the novel RNA polymerase II (pol II) subunit hsRPB4 with its partner hsRPB7 and with pol II. | Mol Cell Biol | 1998 | https://conductscience.org/library/papers/9528765 | PubMed |
| 7 | 11431362 | Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas. | Cancer Res | 2001 | https://conductscience.org/library/papers/11431362 | PubMed |
| 8 | 10784442 | Architecture of RNA polymerase II and implications for the transcription mechanism. | Science | 2000 | https://conductscience.org/library/papers/10784442 | PubMed |
| 9 | 8407810 | A growth rate-limiting process in the last growth phase of the yeast life cycle involves RPB4, a subunit of RNA polymerase II. | J Bacteriol | 1993 | https://conductscience.org/library/papers/8407810 | PubMed |
| 10 | 10973499 | Activation of HIF1alpha ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex. | Proc Natl Acad Sci U S A | 2000 | https://conductscience.org/library/papers/10973499 | PubMed |
| 11 | 7579693 | Human RNA polymerase II subunit hsRPB7 functions in yeast and influences stress survival and cell morphology. | Mol Biol Cell | 1995 | https://conductscience.org/library/papers/7579693 | PubMed |
| 12 | 10944113 | Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein. | EMBO J | 2000 | https://conductscience.org/library/papers/10944113 | PubMed |
| 13 | 9829911 | Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene. | Hum Mutat | 1998 | https://conductscience.org/library/papers/9829911 | PubMed |
| 14 | 9545247 | Structure of wild-type yeast RNA polymerase II and location of Rpb4 and Rpb7. | EMBO J | 1998 | https://conductscience.org/library/papers/9545247 | PubMed |
| 15 | 12019178 | Expression of hypoxia-inducible factors in human renal cancer: relationship to angiogenesis and to the von Hippel-Lindau gene mutation. | Cancer Res | 2002 | https://conductscience.org/library/papers/12019178 | PubMed |
| 16 | 10823831 | Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein. | J Biol Chem | 2000 | https://conductscience.org/library/papers/10823831 | PubMed |
| 17 | 10213691 | Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase. | Science | 1999 | https://conductscience.org/library/papers/10213691 | PubMed |
| 18 | 11292862 | HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. | Science | 2001 | https://conductscience.org/library/papers/11292862 | PubMed |
| 19 | 8488730 | RPB7, one of two dissociable subunits of yeast RNA polymerase II, is essential for cell viability. | Yeast | 1993 | https://conductscience.org/library/papers/8488730 | PubMed |
| 20 | 8187067 | Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas. | Cancer Res | 1994 | https://conductscience.org/library/papers/8187067 | PubMed |
Cited by50
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 81 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42593521 | Recent advances in etiology and treatment of von Hippel-Lindau Disease (VHLD). | Cancer Metastasis Rev | 2026 | https://conductscience.org/library/papers/42593521 | PubMed |
| 41372667 | Dysregulation of the ubiquitin-proteasome system in von Hippel-Lindau syndrome: molecular insights and clinical perspectives. | Clin Exp Med | 2025 | https://conductscience.org/library/papers/41372667 | PubMed |
| 39738247 | SOCS domain targets ECM assembly in lung fibroblasts and experimental lung fibrosis. | Sci Rep | 2024 | https://conductscience.org/library/papers/39738247 | PubMed |
| 38225631 | ARMC5 controls the degradation of most Pol II subunits, and ARMC5 mutation increases neural tube defect risks in mice and humans. | Genome Biol | 2024 | https://conductscience.org/library/papers/38225631 | PubMed |
| 38010567 | A multi-model based on radiogenomics and deep learning techniques associated with histological grade and survival in clear cell renal cell carcinoma. | Insights Imaging | 2023 | https://conductscience.org/library/papers/38010567 | PubMed |
| 37969742 | Function, mechanism and drug discovery of ubiquitin and ubiquitin-like modification with multiomics profiling for cancer therapy. | Acta Pharm Sin B | 2023 | https://conductscience.org/library/papers/37969742 | PubMed |
| 35535400 | Heterogeneous nuclear ribonucleoprotein U-actin complex derived from extracellular vesicles facilitates proliferation and migration of human coronary artery endothelial cells by promoting RNA polymerase II transcription. | Bioengineered | 2022 | https://conductscience.org/library/papers/35535400 | PubMed |
| 35205407 | The Role of VHL in the Development of von Hippel-Lindau Disease and Erythrocytosis. | Genes (Basel) | 2022 | https://conductscience.org/library/papers/35205407 | PubMed |
| 34376376 | Von Hippel-Lindau tumor suppressor pathways & corresponding therapeutics in kidney cancer. | J Genet Genomics | 2021 | https://conductscience.org/library/papers/34376376 | PubMed |
| 33504946 | Tumor-associated antigen Prame targets tumor suppressor p14/ARF for degradation as the receptor protein of CRL2Prame complex. | Cell Death Differ | 2021 | https://conductscience.org/library/papers/33504946 | PubMed |
| 33142830 | Hypoxia and Oxygen-Sensing Signaling in Gene Regulation and Cancer Progression. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/33142830 | PubMed |
| 32947307 | The von Hippel-Lindau Tumor Suppressor Gene: Implications and Therapeutic Opportunities. | Cancer J | 2020 | https://conductscience.org/library/papers/32947307 | PubMed |
| 32621419 | [Targeting Cullin-RING E3 ligases for anti-cancer therapy: efforts on drug discovery]. | Zhejiang Da Xue Xue Bao Yi Xue Ban | 2020 | https://conductscience.org/library/papers/32621419 | PubMed |
| 32603638 | The pVHL neglected functions, a tale of hypoxia-dependent and -independent regulations in cancer. | Open Biol | 2020 | https://conductscience.org/library/papers/32603638 | PubMed |
| 32339495 | Understanding the Oxygen-Sensing Pathway and Its Therapeutic Implications in Diseases. | Am J Pathol | 2020 | https://conductscience.org/library/papers/32339495 | PubMed |
| 30943211 | Genotype-phenotype relations of the von Hippel-Lindau tumor suppressor inferred from a large-scale analysis of disease mutations and interactors. | PLoS Comput Biol | 2019 | https://conductscience.org/library/papers/30943211 | PubMed |
| 30518623 | Bexarotene - a novel modulator of AURKA and the primary cilium in VHL-deficient cells. | J Cell Sci | 2018 | https://conductscience.org/library/papers/30518623 | PubMed |
| 30444862 | Functional Long Noncoding RNAs (lncRNAs) in Clear Cell Kidney Carcinoma Revealed by Reconstruction and Comprehensive Analysis of the lncRNA-miRNA-mRNA Regulatory Network. | Med Sci Monit | 2018 | https://conductscience.org/library/papers/30444862 | PubMed |
| 29562667 | VHL and Hypoxia Signaling: Beyond HIF in Cancer. | Biomedicines | 2018 | https://conductscience.org/library/papers/29562667 | PubMed |
| 28775317 | Interaction between von Hippel-Lindau Protein and Fatty Acid Synthase Modulates Hypoxia Target Gene Expression. | Sci Rep | 2017 | https://conductscience.org/library/papers/28775317 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| POLR2G | 5436 | PubTator's text mining | https://conductscience.org/library/genes/5436 | NCBI Gene |
| VEGFA | 7422 | PubTator's text mining | https://conductscience.org/library/genes/7422 | NCBI Gene |
| VHL | 7428 | PubTator's text mining | https://conductscience.org/library/genes/7428 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/12912922
GET https://conductscience.org/api/papers/v1/12912922/references?page=2